These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 17908965

  • 1. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.
    Shao L, Cui Y, Li H, Liu Y, Zhao H, Wang Y, Zhang Y, Ng KM, Han W, Ma D, Tao Q.
    Clin Cancer Res; 2007 Oct 01; 13(19):5756-62. PubMed ID: 17908965
    [Abstract] [Full Text] [Related]

  • 2. CMTM5-v1 induces apoptosis in cervical carcinoma cells.
    Shao L, Guo X, Plate M, Li T, Wang Y, Ma D, Han W.
    Biochem Biophys Res Commun; 2009 Feb 20; 379(4):866-71. PubMed ID: 19124004
    [Abstract] [Full Text] [Related]

  • 3. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
    Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, Li H, Shu XS, Li H, Liu W, Luo B, Zhang Q, Mok TS, Zheng W, Qiu X, Srivastava G, Yu J, Sung JJ, Chan AT, Ma D, Tao Q, Han W.
    Cancer Res; 2009 Jun 15; 69(12):5194-201. PubMed ID: 19509237
    [Abstract] [Full Text] [Related]

  • 4. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q.
    Oncogene; 2007 Feb 08; 26(6):934-44. PubMed ID: 16862168
    [Abstract] [Full Text] [Related]

  • 5. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.
    Zhang H, Nan X, Li X, Chen Y, Zhang J, Sun L, Han W, Li T.
    Biochem Biophys Res Commun; 2014 May 02; 447(2):304-10. PubMed ID: 24721428
    [Abstract] [Full Text] [Related]

  • 6. CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha.
    Guo X, Li T, Wang Y, Shao L, Zhang Y, Ma D, Han W.
    Biochem Biophys Res Commun; 2009 Sep 11; 387(1):139-42. PubMed ID: 19577543
    [Abstract] [Full Text] [Related]

  • 7. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.
    Niu J, Li H, Zhang Y, Li J, Xie M, Li L, Qin X, Qin Y, Guo X, Jiang Q, Liu Y, Chen S, Huang X, Han W, Ruan G.
    Leuk Res; 2011 Jun 11; 35(6):771-6. PubMed ID: 21168207
    [Abstract] [Full Text] [Related]

  • 8. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
    Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q.
    Clin Cancer Res; 2005 Sep 15; 11(18):6442-9. PubMed ID: 16166418
    [Abstract] [Full Text] [Related]

  • 9. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.
    Breast Cancer Res; 2008 Sep 15; 10(5):R82. PubMed ID: 18826564
    [Abstract] [Full Text] [Related]

  • 10. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, Shi QL, Tang HM, Fu L, Guan XY, Rha SY, Tao Q, He C.
    Oncogene; 2009 Jul 02; 28(26):2466-75. PubMed ID: 19448674
    [Abstract] [Full Text] [Related]

  • 11. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
    Yuan YQ, Xiao YB, Liu ZH, Zhang XW, Xu T, Wang XF.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec 02; 34(6):625-8. PubMed ID: 23286412
    [Abstract] [Full Text] [Related]

  • 12. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
    Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT, Tao Q.
    Oncogene; 2006 Feb 16; 25(7):1070-80. PubMed ID: 16247458
    [Abstract] [Full Text] [Related]

  • 13. DNA methylation and histone modification regulate silencing of OPG during tumor progression.
    Lu TY, Kao CF, Lin CT, Huang DY, Chiu CY, Huang YS, Wu HC.
    J Cell Biochem; 2009 Sep 01; 108(1):315-25. PubMed ID: 19565568
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas.
    Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, Cao Y, Zeng YX, Wong AH, Wang X, Ying J, Srivastava G, Lung ML, Wang LD, Kwok TT, Levi BZ, Chan AT, Sung JJ, Tao Q.
    Oncogene; 2008 Sep 04; 27(39):5267-76. PubMed ID: 18469857
    [Abstract] [Full Text] [Related]

  • 15. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J.
    Oncogene; 2007 Sep 27; 26(44):6456-68. PubMed ID: 17438526
    [Abstract] [Full Text] [Related]

  • 16. IGSF4 promoter methylation and expression silencing in human cervical cancer.
    Li J, Zhang Z, Bidder M, Funk MC, Nguyen L, Goodfellow PJ, Rader JS.
    Gynecol Oncol; 2005 Jan 27; 96(1):150-8. PubMed ID: 15589594
    [Abstract] [Full Text] [Related]

  • 17. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines.
    Dowdy SC, Gostout BS, Shridhar V, Wu X, Smith DI, Podratz KC, Jiang SW.
    Gynecol Oncol; 2005 Oct 27; 99(1):126-34. PubMed ID: 16023706
    [Abstract] [Full Text] [Related]

  • 18. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
    Wang LJ, Jin HC, Wang X, Lam EK, Zhang JB, Liu X, Chan FK, Si JM, Sung JJ.
    Biochem Biophys Res Commun; 2009 Feb 20; 379(4):959-63. PubMed ID: 19135984
    [Abstract] [Full Text] [Related]

  • 19. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.
    Mol Cancer; 2008 Nov 06; 7():83. PubMed ID: 18990230
    [Abstract] [Full Text] [Related]

  • 20. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
    Qiu GH, Salto-Tellez M, Ross JA, Yeo W, Cui Y, Wheelhouse N, Chen GG, Harrison D, Lai P, Tao Q, Hooi SC.
    J Hepatol; 2008 Mar 06; 48(3):433-41. PubMed ID: 18191269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.